In addition, the promoter methylation of IFI44L is a novel and appropriate diagnostic marker for systemic lupus erythematosus (SLE) patients, with a sensitivity of 88.571% and a specificity of 97.087% (13). This evidence concerns the gene IFI44L and systemic lupus erythematosus.